The Anticancer Drug Ellipticine Activated with Cytochrome P450 Mediates DNA Damage Determining Its Pharmacological Efficiencies: Studies with Rats, Hepatic Cytochrome P450 Reductase Null (HRN™) Mice and Pure Enzymes

Author: Stiborová Marie   Černá Věra   Moserová Michaela   Mrízová Iveta   Arlt Volker M.   Frei Eva  

Publisher: MDPI

E-ISSN: 1422-0067|16|1|284-306

ISSN: 1422-0067

Source: International Journal of Molecular Sciences, Vol.16, Iss.1, 2014-12, pp. : 284-306

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content